Back to catalogue
№ 180 27 filings · 2021-09-07 → 2026-05-13

GAMMA COMMUNICATIONS PLC

GAMA
Telecommunications Share price 1,136p Market cap £1.0bn Overall fit 500 /1000

Genuinely cheap for a subscription business with a fortress balance sheet and buyback programme, but the AI-receiver angle is thin (marketing rather than P&L) and operating leverage is only moderate, so it partially — not fully — fits the portfolio thesis.

Fair value range 1,020p–1,200p Mid case · £990m
Absolute upside -2.6% vs current market cap
Conviction 4/5 confidence in undervalued call
Supports the call
  • Clean disclosure and five-year track record of meeting or beating a narrow consensus range
  • Rule 28 compliant FY26 profit forecast reiterated at AGM provides unusual visibility
  • High recurring revenue (89%) and cash conversion (93%) narrow valuation methodology uncertainty
Limits the call
  • Live strategic review makes the standalone valuation a likely floor, not a mid-case
  • Starface (£152m) only c.12 months integrated, so Germany pro-forma run-rate carries residual uncertainty
Methodology

Forward P/E cross-checked with EV/EBITDA and FCF yield

In one line · bull case

Fair-to-cheap UCaaS/telecoms compounder with fortress balance sheet, live strategic review optionality and a Germany-led growth engine — attractive on price and quality despite a thin AI angle.

In one line · biggest risk

Materially thin AI-receiver exposure means the stock captures the 'don't overpay + quality' pillars but not the 'AI beneficiary' pillar of the investor thesis.

Drivers
AI beneficiary 25 /100
Markets AI-led CX and AI voice agents but is a packager of hyperscaler AI, not a receiver of AI capex; no visible AI-driven revenue line
Operating leverage 55 /100
Subscription model with 54% gross margin but acquired German businesses carry higher opex; ~50% incremental margin at scale
Earnings vs expectations 65 /100
Consistent beats or in-line vs conservative management guidance across 2023-2025; H1 2024 formally raised guidance
Growth momentum 55 /100
FY25 revenue +11% reported (+1% organic), FY26 guidance implies 0-3% Adj EBITDA growth — decelerating on tough UK comparators and no new German M&A in the guidance
Moat 55 /100
1,500+ UK channel partners, own regulated telecoms network, high switching costs, but Cisco/Microsoft/hyperscalers commoditise pieces of the stack
Earnings quality 70 /100
93% adjusted cash conversion but £25p gap between statutory 69.3p and adjusted 94.5p EPS reflects heavy acquisition amortisation and multiple 'adjusting items'
Management quality 65 /100
Consistent execution of European roll-up, disciplined capital returns (£64m returned in 2025), but three CFO/CEO transitions since 2022 and 20.65% vote against Chair in 2026
Cyclicality 25 /100
Business-critical B2B comms with 89% recurring revenue; low bad-debt experience even through COVID
Leverage 15 /100
Net debt £9.3m on £141.7m EBITDA (0.07x); £97m of £130m RCF undrawn — effectively net-cash operating balance sheet
Value-trap signals · 3
  • Wide gap between statutory and adjusted EPS driven by recurring 'exceptional' items
  • UK SME macro headwinds compound with PSTN switch-off drag lasting until end-2027
  • 20.65% shareholder vote against Chair re-election at 2026 AGM signals governance friction

GAMMA COMMUNICATIONS PLC (GAMA) — Investment Research Note

Executive summary

Gamma is a UK-listed provider of business-critical cloud communications (UCaaS, calling, SIP, connectivity) serving UK SMEs via a channel-partner network, direct enterprise/public-sector customers, and — post the Placetel (Sep 2024) and Starface (Feb 2025) acquisitions — a materially expanded German business that now contributes ~23% of gross profit. Over 2020–2025 the group has scaled revenue from ~£290m to £645.8m and Adjusted EBITDA from ~£70m to £141.7m, with 89% recurring revenue, 93% cash conversion and ROCE of ~28%, though UK SME growth has slowed under PSTN-switch-off and ethernet-price headwinds while Germany drives the growth story. The single most important valuation point today: the shares trade on ~10.5× FY26 mid-guide adjusted EPS (~92.65p) and ~6.3× EV/EBITDA with net debt only £9.3m — a subscription/telecoms compounder priced closer to a cyclical, which is amplified by an active strategic-review process (talks with counterparties confirmed 13 May 2026).

Fair value estimate

  • Fair value range: 1,020p – 1,200p per share (implied market cap ~£910m – £1,070m), mid ~1,110p / ~£990m
  • Methodology: multiple of forward earnings, cross-checked with EV/EBITDA and FCF yield.
    • P/E: 11–13× FY26 mid consensus adj. EPS of 92.65p (per 12 May 2026 consensus range 90.9–94.4p) → 1,020–1,205p. Peer UCaaS/telecom-adjacent names typically trade at 12–15× when growing; Gamma's mid-single-digit organic growth + 15% inorganic uplift justifies the lower end of that band.
    • EV/EBITDA cross-check: 7–8× FY26 mid EBITDA of £140.5m = EV £984m–£1,124m, less £9.3m net debt = equity £975m–£1,115m. Consistent with the P/E band.
    • FCF yield cross-check: Adjusted FCF FY25 was £80.8m; on ~£990m mid-mcap that is an 8.2% FCF yield — attractive but not distressed.
  • Vs current mcap £870.6m → central upside ~+14%, range from ~+5% to ~+23%.
  • Optionality: takeover discussions are live 2026-05-13 AGM trading update; a control premium would likely push the top end higher, but this note treats it as optionality rather than base case.

Sector context

  • Sector classification (Telecommunications) is technically correct but somewhat misleading — Gamma is closer in economics to a channel-led vertical B2B software/UCaaS business (with a licensed network) than to a consumer telco. Recurring revenue 89%, gross margin 54%, ROCE 28%.
  • Quality/growth profile: above typical Telecom sector peers on margins, ROCE, and recurring-revenue mix; in line to slightly below pure UCaaS peers on organic growth.
  • Listed comparators: BT Group (very different — infrastructure telco), AudioCodes / RingCentral / 8x8 (pure-play UCaaS internationally), NFON AG (closest German cloud-comms comparable), BT-owned Openreach and Virgin Media O2 wholesale on the connectivity side.

Investment thesis (3 bullets)

  • Attractively priced subscription cash-cow with capital return underway. FY25 delivered Adj EBITDA £141.7m, Adj EPS 94.5p, adjusted FCF £80.8m and £64m returned to shareholders; the Board has announced £85m of buybacks across FY26/27 plus a fixed dividend, alongside intact FY26 guidance of £138.1–142.8m EBITDA — implying a ~10.5× P/E and ~10% FCF yield on FY26 numbers 2026-03-24 Final Results; 2026-05-13 AGM trading update.
  • Germany is a genuine growth engine. Placetel + Starface delivered 197% gross-profit growth in Gamma Germany in FY25 to £78.4m (23% of group GP) with 71% gross margin and c.594k cloud seats; management targets Germany reaching UK-comparable scale over time in what is Europe's largest and least-penetrated business-comms market 2026-03-24 Final Results.
  • Live strategic review provides asymmetric optionality. The Board confirmed on 13 May 2026 it remains in preliminary discussions with a number of interested counterparties; given the clean balance sheet, high recurring revenue and depressed rating (52-week low was 701p in March), a takeover offer would likely settle materially above the current price 2026-05-13 AGM trading update.

Key risks (3 bullets)

  • UK SME structural headwinds compound. PSTN switch-off (Jan 2027) caused a net £4m gross-profit drag in FY25 with a similar £4m expected in FY26 lingering into FY27; ethernet-pricing competition in Enterprise cost £2m in FY25 and management expects a further £3m in FY26 2026-03-24 Final Results. UK is >50% of group GP.
  • Integration/deal-execution risk from Starface. £152m Starface acquisition (Feb 2025) added £198m of intangibles including £88.7m customer relationships; goodwill has doubled, and while performance is on track, a single miss in Germany would disproportionately hit the growth thesis 2026-03-24 Final Results, note 13.
  • Weak AI-receiver positioning. Despite marketing language around "AI-led CX" (JD Sports deployment) and AI voice agents, the filings do not evidence AI as a material revenue or margin driver — Gamma is a spender on AI internally and a packager of hyperscaler AI capabilities, not a beneficiary of the AI capex cycle 2026-03-24 Final Results; 2025-09-09 half-year report.

Operating leverage

Gamma's cost structure is a hybrid of high-fixed software/platform costs and semi-variable people/carrier costs. FY25 operating expenses ex-D&A/exceptionals of £187.3m against £348.2m gross profit imply that the fixed/semi-fixed cost base is 54% of gross profit. Gross margin has expanded from 51% (FY22) to 54% (FY25) — largely a mix effect from Starface/Placetel (both above-group gross margins). However, adjusted EBITDA grew only 13% in FY25 vs 16% gross-profit growth because the acquired German businesses "structurally have higher operating expenses" 2026-03-24 Final Results. On the existing UK base, the £7m annualised UK restructuring savings from FY26 (against a £3.3m one-off cost) demonstrates management's ability to right-size fixed costs but also confirms leverage is not dramatic. Illustrative sensitivity: a 10% revenue upside surprise (£65m of incremental revenue) would, at ~50% incremental gross margin on the growth mix and holding UK opex broadly flat, add ~£25–30m to Adjusted EBITDA — roughly a 20% profit lift on 10% revenue. That is moderate operating leverage — meaningful but nowhere near "10-20% revenue beat more than doubles operating profit". This is the weakest pillar for the investor profile.

Value-trap signals

None materially concerning. The UK SME headwinds are real but self-liquidating (PSTN switch-off completes early 2027 and ethernet pricing management expects to stabilise once the market reaches "equilibrium"). Signals to monitor: 20.65% vote against Chair Martin Hellawell re-election at 2026 AGM (governance friction, not fundamental); heavy accounting adjustments (£10.6m exceptional in FY25 for Starface / Main Market listing / UK restructuring; multiple "other adjusting" items) mean the gap between statutory EPS 69.3p and adjusted EPS 94.5p is wide — investors should discount adjusted numbers modestly.

Earnings vs. expectations

Across the 5-year filing window, Gamma has a consistent pattern of meeting or slightly beating management guidance and the top half of sell-side consensus ranges. Specifically: H1 2025 results came in with Adj EBITDA "in line with expectations" but Adj EPS "slightly ahead" [2025-09-09]; the January 2026 pre-close trading update confirmed FY25 Adj EBITDA and Adj EPS within consensus range (£140.0–143.0m EBITDA, 93.6–95.4p EPS), which was subsequently delivered at £141.7m / 94.5p (both above the mid-point); the 13 May 2026 AGM update reiterated FY26 guidance without downgrade; the H1 2024 trading update actually raised guidance to "top half" of the range. Pattern: more beats than in-line, no misses in the period, and management has demonstrated conservative guidance-setting.

Conviction

Conviction: 4 — high. Anchoring factors: (i) very clean and consistent disclosure with a five-year track record of hitting or beating a narrow consensus range; (ii) the business model (89% recurring, 93% cash conversion, net cash) makes DCF/multiples methodologies converge tightly; (iii) FY26 guidance is Rule 28 compliant profit forecast, giving unusual specificity. Limiting factors: (i) the ongoing strategic review means the "no-deal" fair value may be a floor rather than a mid-case; (ii) the Starface acquisition is only ~12 months integrated so the pro-forma Germany run-rate has some uncertainty.

Driver summary

  • Bull one-liner: An 89%-recurring UCaaS/telecoms compounder generating ~10% FCF yield, returning £85m via buybacks and a live strategic review — priced as a UK telco despite German-led growth.
  • Bear one-liner: UK SME headwinds and a demonstrably weak AI-beneficiary story mean this is a "quality-at-a-fair-price" name, not a strategic-thesis winner for an AI-receiver portfolio.
Filings consulted · 30

Every document the LLM read for this note. Click any row to open the source.

  1. 2026-05-13Result OF Agm2026-05-13_9567138_result-of-agm.md0.30
  2. 2026-05-13Agm Trading Update2026-05-13_9565118_agm-trading-update.md0.85
  3. 2026-03-24Final Results2026-03-24_9487860_final-results.md1.00
  4. 2026-01-13Trading Update2026-01-13_9348982_trading-update.md0.72
  5. 2025-09-09Half Year Report2025-09-09_9095019_half-year-report.md0.77
  6. 2025-05-14Agm Trading Update2025-05-14_8876331_agm-trading-update.md0.55
  7. 2025-03-25Final Results2025-03-25_8794823_final-results.md0.65
  8. 2025-02-20Gamma Completes Acquisition OF Starface2025-02-20_8744439_gamma-completes-acquisition-of-starface.md0.49
  9. 2025-01-14Trading Update2025-01-14_8686639_trading-update.md0.55
  10. 2024-09-23Gamma Completes Acquisition OF Placetel2024-09-23_8432793_gamma-completes-acquisition-of-placetel.md0.49
  11. 2024-09-10Half Year Report2024-09-10_8407815_half-year-report.md0.58
  12. 2024-05-21Result OF Agm2024-05-21_8212287_result-of-agm.md0.14
  13. 2024-05-21Agm Trading Update2024-05-21_8209863_agm-trading-update.md0.38
  14. 2024-04-12Publication OF Notice OF Agm2024-04-12_8135985_publication-of-notice-of-agm.md0.14
  15. 2024-03-25Final Results2024-03-25_8103850_final-results.md0.45
  16. 2024-01-16Scheduled Trading Update2024-01-16_7990507_scheduled-trading-update.md0.38
  17. 2023-09-05Half Year Report2023-09-05_7735249_half-year-report.md0.41
  18. 2023-08-02Trading Statement2023-08-02_7669971_trading-statement.md0.21
  19. 2023-05-17Result OF Agm2023-05-17_7531630_result-of-agm.md0.07
  20. 2023-05-17Agm Trading Update2023-05-17_7530010_agm-trading-update.md0.21
  21. 2023-04-20Publication OF Notice OF Agm2023-04-20_7492549_publication-of-notice-of-agm.md0.07
  22. 2023-03-21Final Results2023-03-21_7479979_final-results.md0.25
  23. 2022-09-06Half Year Report2022-09-06_7211577_half-year-report.md0.23
  24. 2022-08-02H1 Trading Update2022-08-02_6956829_h1-trading-update.md0.21
  25. 2022-05-19Result OF Agm2022-05-19_6934947_result-of-agm.md0.07
  26. 2022-05-19Agm Trading Update2022-05-19_6933079_agm-trading-update.md0.21
  27. 2022-04-14Notice OF Agm2022-04-14_6983414_notice-of-agm.md0.07
  28. 2022-03-22Final Dividend Timetable Correction2022-03-22_7006091_final-dividend-timetable-correction.md0.07
  29. 2022-01-12Trading Statement2022-01-12_6809586_trading-statement.md0.21
  30. 2021-09-07Half Year Report2021-09-07_6721545_half-year-report.md0.23

This research note was authored by a large language model after reading 27 regulatory filings published between 2021-09-07 and 2026-05-13. Each citation refers to a specific RNS announcement in the underlying data set. The note is an opinion, not advice. Do your own work before risking capital.